CLINICAL_TRIALS
trial_result
· 2025-07-15
Clinical Trial Update: BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer [Phase 1]
Summary
A Phase 1 trial of BI 836845 in estrogen receptor positive metastatic breast cancer has completed, with results posted in 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2025-07-15